StonvexLoading…
StonvexStonvexStonvexCore line items from AMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.08M | $28.08M | $20.35M | $13.18M |
Operating Income | $-924.00K | $-3.59M | $-2.19M | $-1.84M |
Net Income | $-612.00K | $-1.55M | $-922.00K | $-905.00K |
EPS (Diluted) | $-0.09 | $-0.23 | $-0.14 | $-0.14 |
Total Assets | $54.73M | $55.48M | $59.63M | $63.49M |
Total Liabilities | $28.02M | $27.79M | $31.03M | $34.65M |
Cash & Equivalents | $4.97M | $3.46M | $5.09M | $11.08M |
Free Cash Flow OCF − CapEx | $2.11M | $-4.54M | $-5.82M | $-3.79M |
Shares Outstanding | 6.60M | 6.58M | 6.51M | 6.48M |